Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
Clinical trial NCT06919003 · RECRUITING
Trial details
- NCT number
- NCT06919003
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-22
- Primary completion
- 2031-05-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.